MedPath

A placebo controlled trial of medical treatment of submucous fibroids with Gonadotrophin Releasing Hormone (GnRH) analogues prior to hysteroscopic resectio

Completed
Conditions
Submucous fibroids
Urological and Genital Diseases
Other noninflammatory disorders of uterus, except cervix
Registration Number
ISRCTN75436772
Lead Sponsor
King's College Hospital (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
120
Inclusion Criteria

1. Women with symptomatic submucous fibroids diagnosed on saline infusion hydrosonography
2. Fibroids suitable for hysteroscopic resection
3. Written informed consent obtained

Exclusion Criteria

1. Fibroids not suitable for hysteroscopic resection
2. Written informed consent declined
3. Malignant histology discovered on histological analysis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.